Yang Fei, Wei Yinxiang, Cai Zhijian, Yu Lei, Jiang Lingling, Zhang Chengyan, Yan Huanmiao, Wang Qingqing, Cao Xuetao, Liang Tingbo, Wang Jianli
1] Institute of Immunology, Zhejiang University School of Medicine, Hangzhou, China [2] The Second Affiliated Hospital, Hangzhou, Zhejiang, China.
Institute of Immunology, Zhejiang University School of Medicine, Hangzhou, China.
Cell Mol Immunol. 2015 Jan;12(1):66-76. doi: 10.1038/cmi.2014.21. Epub 2014 Apr 28.
The Fas/FasL system transmits intracellular apoptotic signaling, inducing cell apoptosis. However, Fas signaling also exerts non-apoptotic functions in addition to inducing tumor cell apoptosis. For example, Fas signaling induces lung cancer tumor cells to produce prostaglandin E2 (PGE2) and recruit myeloid-derived suppressor cells (MDSCs). Activated cytotoxic T lymphocytes (CTLs) induce and express high levels of FasL, but the effects of Fas activation initiated by FasL in CTLs on apoptosis-resistant tumor cells remain largely unclear. We purified activated CD8(+) T cells from OT-1 mice, evaluated the regulatory effects of Fas activation on tumor cell escape and investigated the relevant mechanisms. We found that CTLs induced tumor cells to secrete PGE2 and increase tumor cell-mediated chemoattraction of MDSCs via Fas signaling, which was favorable to tumor growth. Our results indicate that CTLs may participate in the tumor immune evasion process. To the best of our knowledge, this is a novel mechanism by which CTLs play a role in tumor escape. Our findings implicate a strategy to enhance the antitumor immune response via reduction of negative immune responses to tumors promoted by CTLs through Fas signaling.
Fas/FasL系统传递细胞内凋亡信号,诱导细胞凋亡。然而,Fas信号除了诱导肿瘤细胞凋亡外,还发挥非凋亡功能。例如,Fas信号诱导肺癌肿瘤细胞产生前列腺素E2(PGE2)并募集髓源性抑制细胞(MDSC)。活化的细胞毒性T淋巴细胞(CTL)诱导并高水平表达FasL,但FasL在CTL中引发的Fas激活对凋亡抗性肿瘤细胞的影响仍不清楚。我们从OT-1小鼠中纯化活化的CD8(+) T细胞,评估Fas激活对肿瘤细胞逃逸的调节作用,并研究相关机制。我们发现CTL通过Fas信号诱导肿瘤细胞分泌PGE2,并增加肿瘤细胞介导的MDSC趋化作用,这有利于肿瘤生长。我们的结果表明CTL可能参与肿瘤免疫逃逸过程。据我们所知,这是CTL在肿瘤逃逸中发挥作用的一种新机制。我们的发现暗示了一种策略,即通过减少CTL通过Fas信号促进的对肿瘤的负性免疫反应来增强抗肿瘤免疫反应。